ÂÜÀòÂÒÂ×

Simon Sung is an experienced executive in the fields of commercial analytics, forecasting, and market research, currently serving as Executive Director at Mineralys Therapeutics, Inc. Since July 2024. Previously, Simon held the position of Senior Director, Head of Commercial Analytics & Forecasting at Lexicon Pharmaceuticals, Inc. from March 2022 to July 2024, and Market Insights Lead at Karyopharm Therapeutics Inc. from November 2020 to March 2022. Simon's extensive career includes significant roles at IQVIA and Pfizer, where responsibilities encompassed planning and implementing performance analytics solutions, coordinating cross-functional launch teams for oncology drugs, and overseeing market research across various therapeutic areas. Prior to these roles, Simon contributed to global market research and analytics at Merck, advising on product launches and marketing strategies. Academic credentials include an MBA from Cornell Johnson Graduate School of Management and a BS in Computer Science and Psychology from Rutgers University.